rs393548
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 2P and 16B. PVS1_ModerateBP6_Very_StrongBA1
The ENST00000600835.6(IL12RB1):c.-109-2A>T variant causes a splice acceptor change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 1,547,552 control chromosomes in the GnomAD database, including 34,726 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
ENST00000600835.6 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL12RB1 | NM_005535.3 | c.-111A>T | 5_prime_UTR_variant | 1/17 | ENST00000593993.7 | NP_005526.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL12RB1 | ENST00000593993.7 | c.-111A>T | 5_prime_UTR_variant | 1/17 | 1 | NM_005535.3 | ENSP00000472165 | P1 |
Frequencies
GnomAD3 genomes AF: 0.212 AC: 32143AN: 151432Hom.: 3487 Cov.: 31
GnomAD3 exomes AF: 0.193 AC: 29266AN: 151862Hom.: 2923 AF XY: 0.195 AC XY: 15839AN XY: 81364
GnomAD4 exome AF: 0.209 AC: 291921AN: 1396002Hom.: 31230 Cov.: 32 AF XY: 0.209 AC XY: 143993AN XY: 689156
GnomAD4 genome AF: 0.212 AC: 32195AN: 151550Hom.: 3496 Cov.: 31 AF XY: 0.212 AC XY: 15731AN XY: 74048
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at